Author:
Ledingham J.,Wilkinson C.,Deighton C.
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Reference8 articles.
1. Keane J. TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology2005;44:714–20.
2. Fischkoff S. Preliminary analysis of phase i and ii safety data from the adalimumab (D2E7) clinical trials program. Proceedings of Advances in Targeted Therapies Meeting, April 27–May 2001.
3. Mohan AK, Cote TR, Block JA, Manadan AM, Siegel JN, Braun MM. Tuberculosis following the use of etanercept, a tumour necrosis factor inhibitor. Clin Infect Dis2004;39:295–9.
4. Wolfe F, Michaud K, Anderson J, Urbansky K. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum2004;50:372–9.
5. Ormerod LP, Milburn HJ, Gillespie S, Ledingham J, Rampton D. BTS recommendations for assessing risk, and for managing M.tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax2005;60:800–5.
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献